Analysts Issue Forecasts for Zoetis' Q3 Earnings (NYSE:ZTS)

Zoetis Inc. (NYSE:ZTS - Free Report) - Investment analysts at Leerink Partnrs boosted their Q3 2025 earnings per share (EPS) estimates for Zoetis in a note issued to investors on Thursday, July 17th. Leerink Partnrs analyst D. Clark now forecasts that the company will earn $1.69 per share for the quarter, up from their previous forecast of $1.68. The consensus estimate for Zoetis' current full-year earnings is $6.07 per share. Leerink Partnrs also issued estimates for Zoetis' Q3 2025 earnings at $1.69 EPS and FY2025 earnings at $6.25 EPS.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.20 billion. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. Zoetis's quarterly revenue was up 1.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.38 earnings per share.

Other equities analysts have also issued reports about the company. Piper Sandler increased their price objective on Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a report on Monday, May 12th. Leerink Partners lowered Zoetis from an "outperform" rating to a "market perform" rating and dropped their price objective for the company from $180.00 to $155.00 in a research note on Thursday. UBS Group lowered their price target on Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 7th. Finally, Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and lowered their price target for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $204.63.

Zoetis Price Performance

Shares of NYSE ZTS opened at $150.21 on Friday. The stock has a fifty day simple moving average of $161.00 and a two-hundred day simple moving average of $161.54. Zoetis has a 1-year low of $139.70 and a 1-year high of $200.33. The firm has a market cap of $66.87 billion, a price-to-earnings ratio of 26.97, a price-to-earnings-growth ratio of 2.51 and a beta of 0.91. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 1.12.

Institutional Investors Weigh In On Zoetis

A number of hedge funds have recently added to or reduced their stakes in ZTS. Nova Wealth Management Inc. purchased a new stake in Zoetis during the 1st quarter valued at $25,000. 1248 Management LLC bought a new stake in shares of Zoetis during the 1st quarter valued at $27,000. Saudi Central Bank bought a new stake in shares of Zoetis during the 1st quarter valued at $29,000. Navigoe LLC bought a new stake in shares of Zoetis during the 4th quarter valued at $30,000. Finally, Cornerstone Planning Group LLC grew its position in shares of Zoetis by 79.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock valued at $30,000 after acquiring an additional 88 shares during the period. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Zoetis news, EVP Roxanne Lagano sold 652 shares of the business's stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total transaction of $110,840.00. Following the completion of the sale, the executive vice president directly owned 15,129 shares in the company, valued at approximately $2,571,930. The trade was a 4.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.18% of the stock is currently owned by insiders.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Investors of record on Friday, July 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.33%. Zoetis's payout ratio is currently 35.91%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.